ResMed (RMD) Revenue — Quarter Ended Mar 31, 2024
Revenue increased during the quarter compared with both the prior quarter and the same period last year. The sequential growth was modest while the year-over-year gain was more pronounced.
Key takeaway
Quarter ended Mar 31, 2024 · FY2024 Q3
Revenue increased during the quarter compared with both the prior quarter and the same period last year. The sequential growth was modest while the year-over-year gain was more pronounced.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$1.2B
Revenue reported for this quarter.
Quarter-over-quarter
+2.9%
Change from the immediately preceding quarter.
Year-over-year
+7.2%
Change from the comparable year-ago quarter.
Trailing four quarters
$4.6B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jun 30, 2023 | $1.1B | +22.7% |
| Sep 30, 2023 | $1.1B | +16.0% |
| Dec 31, 2023 | $1.2B | +12.5% |
| Mar 31, 2024 | $1.2B | +7.2% |
Revenue performance
Revenue exceeded the level reported in the immediately preceding quarter. The company also posted higher revenue than in the same quarter one year earlier.
Quarterly comparison
Compared with the preceding quarter, revenue advanced slightly. Against the same quarter a year ago, the increase was larger, reflecting sustained year-over-year momentum.
What to watch
Monitor whether revenue growth can maintain its year-over-year trajectory in upcoming quarters.